These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9198818

  • 1. [Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer].
    Orzechowska-Juzwenko K, Wiela-Hojeńska A, Milejski P, Cieślińska A, Hudziec P, Adamska M.
    Przegl Lek; 1997; 54(2):103-6. PubMed ID: 9198818
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms].
    Wiela-Hojeńska A, Milejski P, Orzechowska-Juzwenko K, Usnarska-Zubkiewicz L, Urbaniak-Kujda D, Kotlarek-Haus S.
    Przegl Lek; 1997; 54(3):163-6. PubMed ID: 9297191
    [Abstract] [Full Text] [Related]

  • 3. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    Wiela-Hojenska A, Orzechowska-Juzwenko K, Usnarska-Zubkiewicz L, Kotlarek-Haus S, Hurkacz M.
    Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
    Siegmund W, Franke G, Wulkow R, Hanke W, Thonack R.
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
    [Abstract] [Full Text] [Related]

  • 6. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
    Milejski P, Orzechowska-Juzwenko K, Niewiński P, Hurkacz M, Czarnik-Matusewicz H, Leszek J, Rudzik J, Grotthus B.
    Psychiatr Pol; 2007 Dec; 41(2):261-9. PubMed ID: 17598435
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antipyrine metabolism in lung cancer patients and their relatives.
    Radzikowska E, Gazdzik W, Rowińska-Zakrzewska E.
    Rocz Akad Med Bialymst; 1997 Dec; 42 Suppl 1():297-308. PubMed ID: 9337547
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R, Kattner E, Sell-Maurer D, Schloot W.
    Arzneimittelforschung; 1980 Dec; 30(9):1574-9. PubMed ID: 7193028
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease].
    Milejski P, Orzechowska-Juzwenko K, Kamienowski J, Horoch E, Niewiński P, Hurkacz M, Rzemisławska Z.
    Neurol Neurochir Pol; 1999 Dec; 33(5):1015-24. PubMed ID: 10672554
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva].
    Janus K, Baranow-Baranowski S, Jakubowska D.
    Pol Arch Weter; 1991 Dec; 31(3-4):65-71. PubMed ID: 1842615
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S, Lahijany B, Cok I, Karakaya AE.
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.